Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac

Y Yokoyama1, B R Chaitman, R M Hardison

  • 1Saint Louis University Health Sciences Center, Saint Louis, Missouri, USA.

Insights

New electrocardiographic (ECG) abnormalities are more frequent after coronary artery bypass grafting (CABG) than percutaneous transluminal coronary angioplasty (PTCA). Postprocedural Q-wave abnormalities significantly increase long-term cardiac mortality risk for both procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Few studies compare new electrocardiographic (ECG) abnormalities after coronary artery bypass grafting (CABG) versus percutaneous transluminal coronary angioplasty (PTCA).
  • The association between these new ECG abnormalities and long-term cardiac mortality requires further investigation.

Purpose of the Study:

  • To compare the frequency of new ECG abnormalities following CABG versus PTCA.
  • To assess the impact of these new ECG abnormalities on long-term cardiac mortality.

Main Methods:

  • Analysis of 3,373 patients from the Bypass Angioplasty Revascularization Investigation (BARI) trial, randomized or eligible for CABG or PTCA.
  • Comparison of new postprocedural ECG abnormalities (Q waves, ST elevation, T-wave changes) between the two procedures.
  • Assessment of 5-year cardiac mortality rates in relation to new ECG abnormalities.

Main Results:

  • New postprocedural ECG abnormalities were significantly more frequent after CABG than PTCA.
  • Major Q waves, ST-segment elevation, and T-wave abnormalities occurred more often after CABG.
  • The development of new Q-wave abnormalities was associated with a significantly increased adjusted relative risk of 5-year cardiac mortality after both CABG (2.6) and PTCA (4.6).

Conclusions:

  • Patients undergoing CABG exhibit a higher incidence of postprocedural ECG abnormalities compared to those undergoing PTCA.
  • New postprocedural Q-wave abnormalities, regardless of the revascularization strategy, are linked to significantly elevated long-term cardiac mortality.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...